Partial or complete cyclosporine withdrawal convoyed with MMF (Cellcept) administration in kidney allograft recipients
Abstract
About the Authors
M. M. KaabakRussian Federation
J. I. Kurakina
Russian Federation
References
1. Mycophenolate Mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group. Transplantation 1999; 68: 391.
2. Ojo A.O., Meier-Kriesche H.U., Hanson J.A., Leichtman A.B., Cibrik D., Magee J.C., Wolfe R.A., Agodoa L.Y., Kaplan B. MMF reduces late renal allograft loss independently of acute rejection. Transplantation 2000; 69: 2405-2409.
3. Schrama Y., Joles J., van Tol A., Boer P., Koomas H., Hen R. Conversion to MMF according with gradual cylosporine withdrawal in stable kidney graft recipients. Transplantation 2000; 69: 376-383.
4. Houde I., Isenring P., Boucher D., Noel R., Lachanche J.-G. Mycophenolate Mofetil - alternative to cyclosporine А for long-term immunosupression in kidney transplantation. Transplantation 2000; 70: 1251-1253.
5. Aleksic I., Baryalei M., Pieske B., Scorn B., Strauch J., Sorbu H., Dalichau H. Тhe amelioration of a deteriorated function of allografted kidneys in patients receiving Mycophenolate Mofetil and small doses of Sandimmune. Transplantation; 70: 1586-1590.
Review
For citations:
Kaabak M.M., Kurakina J.I. Partial or complete cyclosporine withdrawal convoyed with MMF (Cellcept) administration in kidney allograft recipients. Nephrology and Dialysis. 2002;4(3):191-195. (In Russ.)